Has it been decided as to who is going to deliver PR's message to IOM? Thanx.
Adin -
http://iom.edu/~/media/Files/Activity Files/Disease/MECFS/Agenda27Jan14Website10Jan14.pdf
Has it been decided as to who is going to deliver PR's message to IOM? Thanx.
3. The CCC is an interesting but largely useless systemisation of symptomology.
4. The ICC is useless at best, and probably deserves listing under the nosological heading ‘stupid’.
5. The IOM is the most significant administrative opportunity afforded M.E/CFS patients in 20 years, failure to engage with it fully, bespeaks monumental cowardice or pathological obstinacy.
We can argue forever and about who is 'right' and who is 'wrong' - the point of my post however was not an assertion of correctness but to underline that there is no single patient perspective, and that PR can not and should not claim to 'speak' for all, other than to specifically recognise that M.E/CFS patients (or M.E - encephalitis or encephalopathy - or CFS or CFS/M.E) are a large and diverse group with a multitude of views about their illness(es). If PR wants to pronounce on science or medicine or bureacratic processes, then it must do so on 'it's own cogniscence, not an appeal to authority delivered by a notional monolithic 'community'. I'd also say that simplistic internet 'majoritarianism' is as bad as illegitimately claimed 'community' authority.The purpose of diagnostic criteria is to differentiate a patient population from other patient populations. Unless one field tests criteria on actual subjects, and it proves to be accurate, there are no evidence-based criteria. All we will have from the IOM is an evidence-based hypothesis. And this does not justify its use.
Also, you cannot take evidence from research based on weak criteria to create better criteria. And in the absence of reliable biomarkers, the only way to improve criteria is a combination of evidence and the observations of experts. This is what the CCC and ICC are. The IOM has purposely stacked the committee to limit the number of differing expert opinions, and replace this with people who cannot possible absorb the literature in such a short period of time. So most of the members will not be working from a strong understanding of the evidence, nor do they offer direct experience.
If I had a loved one who was suffering from a serious illness, I would not insist that the medical team include mostly people who have no special knowledge in what my loved one is experiencing. And I would hazard a guess that not one person in the IOM or HHS would with people they care about. Yet, this is what they are doing to us.
I think we can also understand something from the IOM's track record. In their Gulf War Syndrome treatment guide is a section about CFS. I read the sections on graded exercise. They reference three web pages. The web pages offer no citations to studies. The IOM also cites two studies. Neither of them dealt with whether CFS is helped by graded exercise, and one doesn't even mention CFS. They also have a section on pharmaceuticals that only mention pain an sleep control. I have two books that cover much more than this, and they include citations.
I think this shows an underlying weakness in the IOM process. The veterans were making the same complaints we are (ex. not enough experts) before the process was even underway. Yet when we raise these concerns with the IOM, they say they are not responsible for the low-level of scholarship in their past projects, and that the panels are. But they selected the panels and established the quality control. Their web site brags that research will "undergo a rigorous, independent external review by experts." I guess we can see how much good that did. I've seen better work from high school students.
I think that is wrong. Even at the level of saying 'we all want a cure', I doubt that there is an absolute unity given that there will be huge variation in cultral conception of how such a 'cure' would be delivered across a diverse patient group. For some it will be enough that a cure would be available to the wealthiest in certain countries, which in itself has impliations for the direction research.I know we are lacking complete agreement on whether this IOM contract (if it goes forward) will in fact not be a disaster (the prediction of the majority?) but I see us all on the same side still.
We all want the same thing for ourselves and/or our loved ones out of the contract.
PR has not and does not intend to claim to "speak for all". Wally warned of this point in this thread above, and I have included it in my notes on the thread, though I don't think we would ever be likely to do so anyway. The IOM have invited us to present to them regarding what 'aspect or information' we think they should be aware of, and we've asked our members what they think we should say - that's all.We can argue forever and about who is 'right' and who is 'wrong' - the point of my post however was not an assertion of correctness but to underline that there is no single patient perspective, and that PR can not and should not claim to 'speak' for all, other than to specifically recognise that M.E/CFS patients (or M.E - encephalitis or encephalopathy - or CFS or CFS/M.E) are a large and diverse group with a multitude of views about their illness(es). If PR wants to pronounce on science or medicine or bureacratic processes, then it must do so on 'it's own cogniscence, not an appeal to authority delivered by a notional monolithic 'community'. I'd also say that simplistic internet 'majoritarianism' is as bad as illegitimately claimed 'community' authority.
As far as your arguments to my post - I don't understand your logic. Your assessment leads only to the position that description of M.E/CFS (or whatever) is impossible because of a lack of research - which of course leads to there being no research because there is no describable disease.
In the light of research since (1994)Fukada was accepted by the CDC, there's likely room for some pathological reference, but if pathology is made definitely inclusionary, then 90% of Fukada/CCC qualifying patients will almost certainly be excluded and we'll be looking for a new name. It seems very unlikely the IOM would go down such a route given the brief they've been given.
I don't understand your appeal to 'experts' - if we take the lauded 50 then not one has achieved any substantive insight into the illness they are supposedly experts in
I think that is wrong. Even at the level of saying 'we all want a cure', I doubt that there is an absolute unity given that there will be huge variation in cultral conception of how such a 'cure' would be delivered across a diverse patient group. For some it will be enough that a cure would be available to the wealthiest in certain countries, which in itself has impliations for the direction research.
Refusing to acknowledge difference doesn't achieve unity, it simply ends up camoflaguing discrimination and excusing enmity. It's acceptable on PR to consitently denigrate patient organisations which are seen as not being 'us', to the extent of a recent call to destroy one of them. And there's a thread where the son of Jewish escapees from Nazi Germany is directly compared to Hitler because of his professional activities. Assuming the standard levels of M.E/CFS prevalence, then there are around 25,000 Jewish heritage M.E/CFS sufferers in the US alone - I don't see these Godwinesque attacks on someone who happens to be Jewish, as being helpfully 'inclusive' even if not intended as anti Semitic.
There isn't a single unified M.E/CFS 'community' and there is never going to be; what there could be is a reasonably respectful acknowledgment of difference, and commitment to co-operation where it is achievable. However the wish for 'enemies' and the rewards of having someone to attack invariably trumps any such commitment where the internet is the mediating field.
IVI
I am concerned about the current IOM effort. You cannot take evidence from research that is based on mostly weak criteria and use it to create better criteria. And in the absence of reliable biomarkers, the only way to improve criteria is by evaluating the evidence in the context of observations from experts. This is exactly the process that led to the Canadian Consensus Criteria (CCC). And the International Consensus Criteria (ICC) used the same process, although they have not received the same level of vetting. These two sets of criteria were created by experts who spent many years poring over the research and observing it in context of working with patients. Unfortunately, the IOM has chosen to avoid input from a broad range of experts, and instead, put most of the attention on review of a small subset of the many peer reviewed studies. This raises a very real concern that the IOM process cannot possibly reach the same level of accuracy as the CCC.
Also, it is important to keep in mind that the purpose of diagnostic criteria is to differentiate one patient population from other patient populations. It is supposed to be a practical tool that works. Unless your conclusions are field-tested on actual patients, and proven to adequately differentiate them from other types of patients, you have no evidence-based criteria. What you have is a hypothesis based on a limited review of literature.
Please remember that the literature does not define an illness; the manifestations of that illness within the patient population do. And the evidence in literature does not always give a good picture of this. This is especially true with ME/CFS where so many researchers feel free to ignore the syndrome and select patients based on only one symptom (fatigue). That’s why any conclusions drawn here must be tested against the actual patients. This step is not part of the IOM process, and will not be added. I already asked.
As a panel you are in the position to make a recommendation in addition to whatever criteria you come up with. I already confirmed this possibility with the IOM. So I respectfully request that you give the strongest possible recommendation that your criteria not be put into use unless it is field-tested along side of the Canadian Consensus Criteria and shown to be superior in differentiating patients. And that the methods for testing and evaluation should come from a joint venture of recognized experts and the HHS.
There are many advantages to insisting on this kind of test. The CCC has been endorsed by most of the recognized North American experts. It has been observed in use for 10 years. There are strong beliefs among many people that CCC has advantages over doing a limited literature review with no testing. That is why it is so important to test both side-by-side. It will go a long way toward answering many lingering doubts. It will hopefully lead to the best possible criteria that are available with what we know today. And it might even lead to something based on the best of both.
[My underlining.]The purpose of diagnostic criteria is to differentiate a patient population from other patient populations. Unless one field tests criteria on actual subjects, and it proves to be accurate, there are no evidence-based criteria. All we will have from the IOM is an evidence-based hypothesis. And this does not justify its use.
In my wildest dreams PR lists our objections and then a large crowd of patients in jammies appears w/ blanket and pillows and lays down inside venue and outside venue and has a sit- in type protest. Let them carry us out to jail in our jammies.
But w/ our luck even that wouldn't make the news. *sigh*
Oh well. Like I said, it was a wild dream.
So on to a more pragmatic approach.
[omitted]
I’ll make two brief comments on approaching a presentation.
a) If someone invites you to offer an opinion on what they are doing, don’t then insult them by telling them what they are doing is a waste of time, and then expect them to ‘hear’ you. If you don’t like the process – say that, full stop ! Don’t attend a public meeting to say how much the public meeting is stupid/corrupt/wasteful - put the objection in writing, it’ll have far more power.
b) The Government isn’t the enemy. Or is it ? – reading PR re: the IOM issue, I’ve wondered at times how come the HSS or IOM has avoided implication in the Kennedy assassinations, or complicity in the Waco deaths, or be blamed for the Banking crisis. If positive involvement in the IOM process is the intention, then there’s no room for fighting past battles or for ambiguity about whether ‘Government’ is a valid institution. Identify the big issue and convey that – anything else is just indulgent flummery.
And my personal take as a PWME on IOM:
1. The 35/50 (claimed to be) experts were misguided in their initial responses.
2. The 50 claimed experts are nothing of the sort if the area of expertise is M.E/CFS – there can be no expertise in an undefinable medical condition. The fifty include a number who under any circumstances are unworthy to be associated with patient interests.
3. The CCC is an interesting but largely useless systemisation of symptomology.
4. The ICC is useless at best, and probably deserves listing under the nosological heading ‘stupid’.
5. The IOM is the most significant administrative opportunity afforded M.E/CFS patients in 20 years, failure to engage with it fully, bespeaks monumental cowardice or pathological obstinacy.
IVI
Oh my!While that might be eye-catching, my opinion is that the last thing we need to do is present ourselves as a bunch of people laying around in our jammies. Much too likely to reinforce bad stereotypes.
We were proud, working, tax-paying contributors to society before this damned disease hit. This disease has caused great loss to society. That's how we need to present ourselves, imo.
This is EBM in a nutshell. Its a managerial process, not a scientific one. Very rarely is anything actually tested. Its been described as a way to write a succinct summary of the science, and to create simplified recommendations from complex scientific publications.
@Ritto I believe the IOM review will only look at definition and not at treatment so it is believed that PACE will not be as much as a factor as it might have been.